Nucleic Acid Amplification Testing Market Size, Share & Trends Analysis Report By Application (Infectious Diseases, Cancer, Personalized Medicine, Genetic), By Technique (target amplification, probe amplification, & signal amplification), And Segment Forecasts, 2018 - 2025

Industry Insights

The global nucleic acid amplification testing market size was valued at USD 1.78 billion in 2015. Growing demand for the advanced diagnostic measures and increasing investments for development of new biotechnological diagnostic techniques are the key factors propelling the growth of market. In addition, the growing prevalence of infectious diseases associated with vectors like bacteria & viruses are also fueling the overall growth.

The global prevalence of the communicable diseases remains high despite the presence of various diagnostic and therapeutic techniques in the market. The successful management of an infectious disease is highly dependent on accurate identification of the infecting agent. Nucleic acid amplification provides the most precise detection technique for most of the infectious agents. Thus, it is preferred over traditional diagnostic techniques. In addition, favorable initiatives undertaken by the governments worldwide to introduce these tests in various screening programs is expected to impact the sector positively, especially during the former half of the forecast period.

India Nucleic Acid Amplification Testing Market, By Application, 2014 - 2025 (USD Million)

Along with infectious diseases, NAAT are being extensively studied for applications in the others fields like cancer, personalized medicine, and forensics. This is expected to spur the demand for NAAT during the forecast period.

Application Insights

Infectious diseases captured the largest share in 2015 owing to high usage of NAAT for detection of disease causing bacteria and viral agents. Growing emphasis on management of epidemics, including the most recent one of Zika virus, is expected to maintain the largest share of the segment throughout the forecast period.

Constantly rising burden of mortality of cancer across the world is catching the attention of healthcare agencies. Thus, high demand for effective early diagnostic methods for various cancer types is anticipated to drive the growth of the segment with a significant CAGR during the forecast period.

Technique Insights

The target amplification system includes PCR technology, which is widely used because of its operational simplicity and high efficiency. Thus, the segment is expected to dominate the nucleic acid amplification testing market throughout the forecast period with the highest CAGR.

Many of the companies had limited access to the PCR techniques till 2006. Because of the limited access, the alternative techniques like signal and probe amplification systems were developed. These techniques have applications in the selective cases. These techniques are used in place of PCR to minimize the time and money required for diagnosis in cases such as branched DNA probes and anti DNA-RNA hybrid antibodies.

Global Nucleic Acid Amplification Testing Market, by Technique, 2015

Regional Insights

North America dominated the sector with the largest revenue share in 2015. Factors like presence of a large number of players, well-developed healthcare system, high disposable income, and favorable reimbursement policies are contributing in high revenue generation in the region.

Asia Pacific is expected to show the fastest growth from 2016 to 2025, due to presence of fast growing economies and favorable demographics, such as high prevalence of infectious diseases, and rising adoption of the advanced diagnostic technologies. The government initiatives to implement NAT in the public health services is anticipated to create growth opportunities in the region.

Nucleic Acid Amplification Testing Market Share Insights

This market is highly competitive with a few players capturing the most of the share. These companies focus more on the new product development to maintain their share. Geographical expansion is of strategic importance to maintain competitiveness. Fast growing biotechnology space in Asia Pacific is expected to give rise to the number of local players in the region.

Some of the major players operating in this sector include F. Hoffmann-La Roche Ltd; Becton, Dickinson and Company; Beckman Coulter, Inc.; Abbott Laboratories, Inc.; Illumina, Inc.; Siemens Healthineers; bioMérieux SA; Novartis AG; and Bio-Rad Laboratories, Inc.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, & country levels and provides an analysis on the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the nucleic acid amplification testing market on the basis of application, techniques, and region:

• Application Outlook (Revenue, USD Million, 2014 - 2025)

  • Infectious Diseases

    • Virus

    • Bacteria

    • Others

  • Cancer

  • Personalized Medicine

  • Genetic and Mitochondrial Disorders

• Technique Outlook (Revenue, USD Million 2014 - 2025)

  • Target amplification systems

  • Probe amplification systems

  • Signal amplification

• Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • China

    • India

  • Latin America

    • Mexico

    • Brazil

  • MEA

    • South Africa